| scholarly article | Q13442814 |
| P50 | author | Ming Tan | Q115232766 |
| P2093 | author name string | Ming Xia | |
| Pengwei Huang | |||
| Xi Jiang | |||
| Wen Jiang | |||
| Chao Wei | |||
| Weiming Zhong | |||
| Monica McNeal | |||
| Ping-An Fang | |||
| P2860 | cites work | The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors | Q24563224 |
| Structural basis for the recognition of blood group trisaccharides by norovirus | Q24682901 | ||
| X-ray crystallographic structure of the Norwalk virus capsid | Q27619935 | ||
| Crystal structure of Thermotoga maritima alpha-L-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis | Q27642919 | ||
| Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*) | Q27643845 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| EMAN: semiautomated software for high-resolution single-particle reconstructions | Q27860772 | ||
| A viral nanoparticle with dual function as an anthrax antitoxin and vaccine | Q28469319 | ||
| Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles | Q33649920 | ||
| Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns | Q33788719 | ||
| Functional mapping of protective domains and epitopes in the rotavirus VP6 protein | Q33812420 | ||
| The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors | Q34123964 | ||
| Mutations within the P2 Domain of Norovirus Capsid Affect Binding to Human Histo-Blood Group Antigens: Evidence for a Binding Pocket | Q34275858 | ||
| Structural requirements for the assembly of Norwalk virus-like particles | Q34335587 | ||
| C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. | Q35023707 | ||
| Structures of picorna-like plant viruses: implications and applications | Q35627066 | ||
| Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. | Q36415015 | ||
| Noroviral P particle: structure, function and applications in virus-host interaction | Q36429481 | ||
| Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4 | Q36687427 | ||
| Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein | Q36695213 | ||
| Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines | Q36948876 | ||
| Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. | Q37163704 | ||
| Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice | Q38309590 | ||
| Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns | Q38353300 | ||
| Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines | Q41052916 | ||
| The development of cowpea mosaic virus as a potential source of novel vaccines | Q41259575 | ||
| Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy | Q41635844 | ||
| Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus | Q42157032 | ||
| Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus | Q44986374 | ||
| A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula | Q45519794 | ||
| Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials | Q45729039 | ||
| Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus | Q45742333 | ||
| Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides | Q45781264 | ||
| Presentation of heterologous peptides on plant viruses: genetics, structure, and function | Q46075765 | ||
| E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. | Q54497752 | ||
| A 11.5 A single particle reconstruction of GroEL using EMAN | Q77218030 | ||
| Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes | Q78805133 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| antibody | Q79460 | ||
| genetic vector | Q427389 | ||
| norovirus | Q1142751 | ||
| P304 | page(s) | 753-764 | |
| P577 | publication date | 2010-11-10 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Norovirus P particle, a novel platform for vaccine development and antibody production | |
| Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production | |||
| P478 | volume | 85 |
| Q47151435 | A Bacterial Surface Display System Expressing Cleavable Capsid Proteins of Human Norovirus: A Novel System to Discover Candidate Receptors. |
| Q35301295 | A candidate dual vaccine against influenza and noroviruses |
| Q45362011 | A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles |
| Q37716268 | A dual chicken IgY against rotavirus and norovirus |
| Q37502688 | A dual vaccine candidate against norovirus and hepatitis E virus |
| Q40925262 | A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice |
| Q36519453 | A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus |
| Q64239479 | Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice |
| Q34464196 | Affinities of recombinant norovirus P dimers for human blood group antigens |
| Q30388370 | Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells |
| Q92163398 | Application of a multiplex salivary immunoassay to detect sporadic incident norovirus infections |
| Q89065119 | Application of a salivary immunoassay in a prospective community study of waterborne infections |
| Q91576751 | Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform |
| Q34064413 | Branched-linear and agglomerate protein polymers as vaccine platforms |
| Q28477791 | Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay |
| Q39471943 | Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China |
| Q47547891 | Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model. |
| Q36157186 | Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children |
| Q36210208 | Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates. |
| Q27671411 | Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens |
| Q43486086 | Detection of a novel recombinant strain of norovirus in an African-descendant community from the Amazon region of Brazil in 2008. |
| Q36914794 | Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus |
| Q104289416 | Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine |
| Q35250141 | Energetic changes caused by antigenic module insertion in a virus-like particle revealed by experiment and molecular dynamics simulations |
| Q36391936 | Engineering Bacterial Surface Displayed Human Norovirus Capsid Proteins: A Novel System to Explore Interaction Between Norovirus and Ligands. |
| Q36392947 | Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles |
| Q36970026 | Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B. |
| Q52760693 | Glycan-specificity of four neuraminidase-sensitive animal rotavirus strains. |
| Q30234848 | Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy |
| Q57093839 | Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses |
| Q35008592 | Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay |
| Q92759295 | Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice |
| Q24810360 | Immunogenetic mechanisms driving norovirus GII.4 antigenic variation |
| Q41077794 | Immunogenicity and protective efficacy of the norovirus P particle-M2e chimeric vaccine in chickens. |
| Q40632924 | Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen |
| Q34059409 | Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs |
| Q34985473 | Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens |
| Q40283651 | Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study |
| Q40261280 | Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study. |
| Q90231715 | Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development |
| Q34702360 | Norovirus P particle efficiently elicits innate, humoral and cellular immunity |
| Q36445296 | Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus |
| Q52726208 | Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. |
| Q36275589 | Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives |
| Q38698429 | Norovirus vaccines under development |
| Q37135476 | Norovirus vaccines: Correlates of protection, challenges and limitations |
| Q38217316 | Norovirus: targets and tools in antiviral drug discovery |
| Q36792270 | Polyvalent complexes for vaccine development |
| Q38929391 | Production of Brazilian human norovirus VLPs and comparison of purification methods |
| Q40102851 | Prospects and Challenges in the Development of a Norovirus Vaccine |
| Q90043367 | Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens |
| Q37195802 | Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses. |
| Q38819439 | Recent advancements in combination subunit vaccine development |
| Q38820980 | Reverse osmosis integrity monitoring in water reuse: The challenge to verify virus removal - A review |
| Q41841490 | Secreted production of assembled Norovirus virus-like particles from Pichia pastoris |
| Q35943850 | Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner |
| Q38301692 | Strain-specific interaction of a GII.10 Norovirus with HBGAs |
| Q39604515 | Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses. |
| Q58546290 | Structural adaptations of norovirus GII.17/13/21 lineage through two distinct evolutionary paths |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q36267431 | Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens. |
| Q34724844 | Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles |
| Q83274630 | The formation of P particle increased immunogenicity of norovirus P protein |
| Q40044140 | Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future |
| Q26799737 | Tropical and travel-associated norovirus: current concepts |
| Q33578075 | Vaccine against norovirus |
| Q27004488 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae |
Search more.